Assessment of cardiovascular risk in patients with gout and nonalcoholic fatty liver disease


  • S. I. Smiyan Ternopil State Medical University,
  • S. V. Danchak Ternopil State Medical University,



Gout, Liver Diseases, Cardiovascular Diseases


Aim. Cardiovascular diseases are observed more frequently in patients with gout as compared to other rheumatologic pathologies.

Methods and results. 120 patients with gout were examined to study the frequency of cardiovascular risk in patients combined with nonalcoholic fatty liver disease (NAFLD). To determine cardiovascular risk SCORE chart was used, the diagnosis of nonalcoholic fatty liver disease was confirmed by share wave elastography.

Conclusion. In patients with gout and nonalcoholic fatty liver disease there is increasing of cardiovascular risk level, low cardiovascular risk is found in 16.2%, moderate in 25.0%, high in 19.1% and very high risk in 39.7% of cases. Among patients without associated liver injury another tendency is observed, particularly low risk was found in 32.7%, moderate in 40.4%, high in 17.3% and very high risk in 9.6% of cases. Risk factors for cardiovascular disease in patients with gout combined with nonalcoholic fatty liver disease include hypertension, hypercholesterolemia, hyperuricemia, smoking, an increase of patients’ age, body mass index. The level of hyperuricemia was significantly (p <0.01) higher among patients with nonalcoholic fatty liver disease patients and increased together with increasing risk of cardiovascular catastrophes.


Meek, I. L., Picavet, H. S., Vonkeman, H. E., Verschuren, W. M., & van de Laar, M. A. (2013). Increased cardiovascular risk factors in different rheumatic diseases compared with the general population. Rheumatology (Oxford), 52, 210–216. doi: 10.1093/rheumatology/kes194.

Roddy, E., & Doherty, M. (2010). Epidemiology of gout Arth. Res. Ther, 12(223), 1–11. doi: 10.1186/ar3199.

Bhatia, L. S. (2012). Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor? Eur. Heart J, 33, 1190–1200. doi: 10.1093/eurheartj/ehr453.

Kolesnikova, O. V., Babak, O. Ya., Solomentseva, T. A., Kurinna, O. G., & Sytnyk, K. O. (2013). Osoblyvosti vuhlevodnoho ta lipidnoho obminu u khvorykh na nealkoholnu zhyrovu khvorobu pechinky zalezhno vid stupenia kardiovaskuliarnoho ryzyku [Carbohydrate and lipid metabolism features in patients with nonalcoholic fatty liver disease, depending on the degree of cardiovascular risk]. Suchasna hastroenterolohiia, 6, 7–12. [in Ukrainian].

Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., et al. (2012) The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology, 55(6), 2005–23. doi: 10.1002/hep.25762.

Sung, K. C., Wild, S. H., Kwag H. J., & Byrne, C. D. (2012). Fatty liver, insulin resistance, and features of metabolic syndrome: relationships with coronary artery calcium in 10,153 people. Diabetes Care, 35, 2359–2364. doi: 10.2337/dc12-0515.

Chen, S. H., He, F., Zhou, H. L., Wu, H. R., Xia, C., & Li, Y. M. (2011). Relationship between nonalcoholic fatty liver disease and metabolic syndrome. J. Dig. Dis, 12, 125–130. doi: 10.1111/j.1751-2980.2011.00487.x.

Zhang, Y., Hong, Q., Huang, Z., Xue, P., Lv, Y., & Fu, B. (2014). ALDR enhanced endothelial injury in hyperuricemia screened using SILAC. Cell. Physiol. Biochem, 33(2), 479–490. doi: 10.1159/000358628.

Stepanova, M., & Younossi, Z. M. (2012). Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population. Clin. Gastroenterol. Hepatol, 10(6), 646–650. doi: 10.1016/j.cgh.2011.12.039.

Targher, G., Zoppini, G., & Day, C. P. (2011). Risk of all-cause and cardiovascular mortality in patients with chronic liver disease. Gut, 60, 1602–1603. doi:10.1136/gut.2010.230656.

How to Cite

Smiyan SI, Danchak SV. Assessment of cardiovascular risk in patients with gout and nonalcoholic fatty liver disease. Pathologia [Internet]. 2015Dec.18 [cited 2024Apr.16];(3). Available from:



Original research